ADVFN ADVFN

Hot Features

Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Royalty Pharma PLC

Royalty Pharma PLC (RPRX)

54,97
0,96
(1,78%)
Fermé 04 Juin 10:00PM
54,086
-0,884
(-1,61%)
Après les heures de négociation: 1:28AM

Royalty Pharma PLC (RPRX) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
54,086
( 0,14% )
Prix Achat
53,80
Prix Vente
55,00
Volume échangé
4 469 977
53,945 Fourchette du Jour 55,505
32,85 Plage de 52 semaines 56,07
Cap du marché
Clôture Veille
54,01
Ouverture
54,18
Dernière Transaction
2
@
54.98
Dernière heure de transaction
Volume financier
US$ 247 108 656
VWAP
55,2819
Volume moyen (3 m)
US$ 3 564 688
Actions en circulation
443 274 104
Rendement du Dividende (LTM)
0,9 (1,78%)
Ratio Cours sur Bénéfices
29,28
Bénéfice par action (BPA)
1,9
Chiffre d'affairess (LTM)
2,44B
Bénéfice net (LTM)
826,29M

À propos de Royalty Pharma PLC

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therape... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
New York, United States
Fondé
1996
Royalty Pharma PLC est coté dans le secteur Healthcare de la NASDAQ avec le ticker RPRX. Le dernier cours de clôture d'Royalty Pharma était de US$54,01. Au cours de la dernière année, les actions de Royalty Pharma ont été négociées dans une fourchette de prix de US$ 32,85 à US$ 56,07.

Royalty Pharma compte actuellement 443 274 104 actions en circulation. La capitalisation boursière d'Royalty Pharma est de US$23,97 milliard. Royalty Pharma a un ratio cours/bénéfice (ratio PE) de 29.28.

RPRX Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.2460.4569093610753.8456.0753.5642255355.19080802CS
42.7965.4513550399751.2956.0749.2775439822253.39014983CS
128.14617.731824118445.9456.0744.73346692850.22589911CS
2614.63637.100126742739.4556.0737.83364123245.45717707CS
5220.95663.253848475733.1356.0732.85375423240.82896884CS
15620.63661.69207772833.4556.0724.05326516633.86295473CS
26011.18626.074592074642.956.0724.05275547035.56486587CS

RPRX - Frequently Asked Questions (FAQ)

What is the current Royalty Pharma PLC share price?
The current share price of Royalty Pharma PLC is US$ 54,086
How many Royalty Pharma PLC shares are in issue?
Royalty Pharma PLC has 443 274 104 shares in issue
What is the market cap of Royalty Pharma PLC?
The market capitalisation of Royalty Pharma PLC is USD 23,97B
What is the 1 year trading range for Royalty Pharma PLC share price?
Royalty Pharma PLC has traded in the range of US$ 32,85 to US$ 56,07 during the past year
What is the PE ratio of Royalty Pharma PLC?
The price to earnings ratio of Royalty Pharma PLC is 29,28
What is the cash to sales ratio of Royalty Pharma PLC?
The cash to sales ratio of Royalty Pharma PLC is 10,13
What is the registered address of Royalty Pharma PLC?
The registered address for Royalty Pharma PLC is 110 East 59th Street, New York, New York, 10022
What is the Royalty Pharma PLC website address?
The website address for Royalty Pharma PLC is www.royaltypharma.com
Which industry sector does Royalty Pharma PLC operate in?
Royalty Pharma PLC operates in the Biotechnology & Life Sciences sector

RPRX Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock